Michael G. Kauffman
2014
In 2014, Michael G. Kauffman earned a total compensation of $648.8K as Chief Executive Officer at Karyopharm Therapeutics, a 91% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $198,000 |
|---|---|
| Salary | $440,000 |
| Other | $10,820 |
| Total | $648,820 |
Kauffman received $440K in salary, accounting for 68% of the total pay in 2014.
Kauffman also received $198K in non-equity incentive plan and $10.8K in other compensation.
Rankings
In 2014, Michael G. Kauffman's compensation ranked 9,361st out of 13,032 executives tracked by ExecPay. In other words, Kauffman earned more than 28.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,361 out of 13,032 | 28th |
Division Manufacturing | 3,520 out of 4,966 | 29th |
Major group Chemicals And Allied Products | 1,193 out of 1,686 | 29th |
Industry group Drugs | 944 out of 1,365 | 31st |
Industry Pharmaceutical Preparations | 722 out of 1,043 | 31st |
Source: SEC filing on April 29, 2016.
Kauffman's colleagues
We found four more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2014.
2014
Justin Renz
Karyopharm Therapeutics
Chief Financial Officer
2014
Ran Frenkel
Karyopharm Therapeutics
Executive Vice President, Worldwide Development Operations
2014
Christopher Primiano
Karyopharm Therapeutics
General Counsel
2014
Sharon Shacham
Karyopharm Therapeutics
Chief Scientific Officer
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019